Baxion
ScreeningTagsAlerts

Endra Life Sciences Inc.

NDRA·NASDAQ·$5.20Share Price as of 11/2·$4MMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/14/2610-QQ1 ended 03/31/2605/15/2610-KFY 202503/31/2610-QQ3 ended 09/30/2511/14/2510-QQ2 ended 06/30/2508/14/25

Disclosures

8-KCurrent report10/01/268-KCurrent report08/17/268-KCurrent report07/09/268-KCurrent report06/26/268-KCurrent report06/25/26

Prospectuses and Registrations

S-4Registration (business combination)10/02/26S-8Registration of securities for employees05/15/26424B4Prospectus11/26/25S-3Shelf registration11/06/25424B5Prospectus supplement10/30/25

Proxies

DEF 14ADefinitive proxy10/28/25DEFA14AAdditional proxy materials10/28/25PRE 14APreliminary proxy10/17/25DEFA14AAdditional proxy materials09/17/24DEF 14ADefinitive proxy09/16/24

Ownership

SC 13D/ABeneficial ownership (amended)06/29/26144Proposed sale of securities06/25/26Form 4Insider transaction03/04/26Form 4Insider transaction03/04/26Form 4Insider transaction01/23/26

Other

42542510/01/2642542509/25/2642542509/14/2642542509/09/2642542509/09/26

Latest Filings

S-4Registration (business combination)10/02/268-KCurrent report10/01/2642542510/01/2642542509/25/2642542509/14/26

Ownership

SC 13D/ABeneficial ownership (amended)06/29/26144Proposed sale of securities06/25/26Form 4Insider transaction03/04/26Form 4Insider transaction03/04/26Form 4Insider transaction01/23/26
  • Baxion © 2026
  • Terms
  • Privacy
  • Contact